000919 Jinling Pharmaceutical
- 7.14
- -0.13-1.79%
Jinling Pharmaceutical News
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the acquisition of part of the shares of the Xingong Fund and the non-cash distribution of shares in the Xingong Fund and related transactions
Jinling Pharmaceutical: 2024-093 Announcement of Jinling Pharmaceutical Co., Ltd. on the completion of the cancellation of some restricted stock repurchases
Jinling Pharmaceutical: Legal Opinion on the Implementation of Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan to Repurchase and Cancel Some Restricted Shares
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on issuing some restricted shares to specific targets and releasing restricted listing and circulation
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s acquisition of part of the Nanjing Xingong Medical Industry Investment Fund Partnership (Limited Partnership) fund shares and related transactions
Jinling Pharmaceutical: Verification Opinions of CITIC Securities Co., Ltd. on Jinling Pharmaceutical Co., Ltd.\'s acquisition of part of the shares of Xingong Fund and the non-cash distribution of shares in Xingong Fund and related transactions
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the acquisition of part of the shares of the Xingong Fund and the non-cash distribution of shares in the Xingong Fund and related transactions
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the repurchase price of the 2021 Restricted Stock Incentive Plan and the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Repurchase Price Adjustment and Repurchase Cancellation of Some Restricted Shares
Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. 2023 Equity Distribution Implementation Notice
Jinling Pharmaceutical: CITIC Securities Co., Ltd. listing sponsorship for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023
Jinling Pharmaceutical: Announcement on the issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets in 2023
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on passively diluting the shareholders' shareholding ratio by more than 1%
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of stock listing notices issued to specific targets
Jinling Pharmaceutical: Capital Verification Report on the Issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets to raise capital
Jinling Pharmaceutical: Report on the issuance of A-shares to specific targets by Jinling Pharmaceutical Co., Ltd. in 2023
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of a report on the issuance of shares to specific targets
Jinling Pharmaceutical: Report of CITIC Securities Co., Ltd. on the issuance process of Jinling Pharmaceutical Co., Ltd.\'s issuance process of A-shares to specific targets in 2023 and compliance with subscription targets
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the issuance process of Jinling Pharmaceutical Co., Ltd. to issue A shares to specific targets in 2023 and compliance with subscription targets
Jinling Pharmaceutical: CITIC Securities Co., Ltd.'s inspection opinions on extending the validity period of the resolution of Jinling Pharmaceutical Co., Ltd.'s shareholders' meeting in 2023 to issue A shares to specific targets and the validity period of
No Data
